After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ZLAB belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Zai Lab Limited ADR is $2.76B. A total of 0.67 million shares were traded on the day, compared to an average of 930.80K shares.
In the most recent transaction, Chen Kai-Xian sold 7,750 shares of ZLAB for 17.22 per share on Jul 01 ’24. After the transaction, the Director now owns 60,778 company shares. In a previous transaction on Dec 31 ’24, Amado Rafael sold 7,583 shares at 26.28 per share. ZLAB shares that the insider owns now total 33,834.
Among the insiders who bought shares, Amado Rafael acquired of 7,583 shares on Dec 31 ’24 at a per-share price of $26.28. In another insider transaction, Chen Yajing sold 167 shares at $30.66 per share on Nov 04 ’24. Company shares held by the Chief Financial Officer now total 15,494.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ZLAB has a high of $36.60 and a low of $13.48.
As of this writing, ZLAB has an earnings estimate of -$0.69 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.48 per share and a lower estimate of -$0.79.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ZLAB’s latest balance sheet shows that the firm has $1.41B in Cash & Short Term Investments as of fiscal 2021. There were $15.54M in debt and $192.90M in liabilities at the time. Its Book Value Per Share was $6.78, while its Total Shareholder’s Equity was $1.38B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZLAB is Buy with a score of 5.00.
